Expedient Route to Tris(hetero)aryl Systems
and 1,10-phenanthroline (0.40 mmol) was added sequentially to a
mixture of the N-heterocycle (4.8 mmol), CuI (0.20 mmol) and
Cs2CO3 (8.0 mmol) in dry degassed DMF (4 mL). The mixture was
stirred and heated under argon at 80 °C until TLC monitoring
showed that the reaction was complete (typically ca. 24 h). The
reaction mixture was cooled to room temperature, diluted with
ethyl acetate (10 mL) and washed through a pad of silica gel with
ethyl acetate (ca. 40 mL) to remove inorganic materials. The eluent
was concentrated in vacuo and the product was purified either by
recrystallization or by chromatography on a silica gel column.
sample prepared by the two-step procedure, as described in the
Supporting Information.
Supporting Information (see also the footnote on the first page of
this article): Experimental methods (p. S2–S9), copies of NMR
spectra (p. S10–S28.
CCDC-665603 contains supplementary crystallographic data
for compound 22. These data can be obtained free of charge
from The Cambridge Crystallographic Data Centre via
www.ccdc.cam.ac.uk./data_request/cif.
1-(5-Bromopyridin-2-yl)-1H-benzimidazole (12): Chromatography
(eluent EtOAc/Et2O, 9:1 v/v) yielded 12 as a white solid in 90%
yield, m.p. 159.6–160.5 °C. H NMR (400 MHz, CDCl3): δ = 8.61
Acknowledgments
1
(d, J = 2.0 Hz, 1 H), 8.51 (s, 1 H), 8.00–7.94 (m, 2 H), 7.86–7.84
(m, 1 H), 7.44 (dd, J = 8.4, 0.4 Hz, 1 H), 7.39–7.32 (m, 2 H) ppm.
13C NMR (100 MHz, CDCl3): δ = 150.7, 148.8, 145.0, 141.7, 141.3,
We thank the Engineering and Physical Sciences Research Council
(EPSRC) for financial support via a DTA award (to J. S. S.).
132.2, 124.7, 123.8, 121.1, 117.9, 115.4, 112.9 ppm. IR (ν
=): ν
˜
˜
max
= 3080, 3051, 1578, 1499, 1476, 1203, 741 cm–1. MS (EI): m/z =
273 (100) [M+, 79Br], 275 (97) [81Br]. C12H8BrN3 (274.1): calcd. C
52.58, H 2.94, N 15.33; found C 52.53, H 2.83, N 15.19.
[1] Reviews: a) S. V. Ley, A. W. Thomas, Angew. Chem. Int. Ed.
2003, 42, 5400–5449; b) D. Alberico, M. E. Scott, M. Lautens,
Chem. Rev. 2007, 107, 174–238; c) L.-C. Campeau, K. Fagnou,
Chem. Soc. Rev. 2007, 36, 1058–1068; d) I. V. Seregin, V. Ge-
vorgyan, Chem. Soc. Rev. 2007, 36, 1173–1193; e) Metal-Cata-
lyzed Cross-Coupling Reactions, 2nd edition (Eds.: A. de Mei-
jere, F. Diederich), Wiley-VCH, Weinheim, 2004; f) for a review
which emphasizes the patent literature, see: J.-P. Corbet, G.
Mignani, Chem. Rev. 2006, 106, 2651–2710; g) L.-C. Campeau,
D. R. Stuart, K. Fagnou, Aldrichimica Acta 2007, 40, 35–41.
[2] Reviews: a) N. Miyaura, A. Suzuki, Chem. Rev. 1995, 95, 2457–
2483; b) N. Miyaura, Top. Curr. Chem. 2002, 219, 11–59; c)
Boronic Acids: Preparation and Applications in Organic Synthe-
sis and Medicine (Ed.: D. G. Hall), Wiley-VCH, Weinheim,
2005; d) F. Bellina, A. Carpita, R. Rossi, Synthesis 2004, 2419–
2440.
General Procedure for the Suzuki–Miyaura Cross-Coupling Reac-
tions with Aryl/Heteroaryl Boronic Acids: Aqueous Na2CO3 (1 ,
4 mL) was added to a mixture of the aryl halide (1.8 mmol), the
boronic acid (2.0 mmol) and catalyst (0.1 mmol) in 1,4-dioxane
(8 mL). The mixture was stirred and heated at 80 °C until TLC
monitoring showed that reaction was complete. The mixture was
cooled to room temperature, solvent was removed in vacuo and
EtOAc (50 mL) was added to the residue which was washed with
brine (3ϫ50 mL). The organic layer was separated, concentrated
in vacuo and the product was purified by chromatography on a
silica gel column.
[3] a) T. Okazawa, T. Satoh, M. Miura, M. Nomura, J. Am. Chem.
Soc. 2002, 124, 5286–5287; b) F. Bellina, C. Calandri, S. Cau-
teruccio, R. Rossi, Tetrahedron 2007, 63, 1970–1980; c) L.-C.
Campeau, S. Rousseaux, K. Fagnou, J. Am. Chem. Soc. 2005,
127, 18020–18021; d) F. Bellina, S. Cauteruccio, R. Rossi, Eur.
J. Org. Chem. 2006, 1379–1382; e) F. Bellina, S. Cauteruccio,
R. Rossi, J. Org. Chem. 2007, 72, 8543–8546; f) X. Wang, D. V.
Gribkov, D. Sames, J. Org. Chem. 2007, 72, 1476–1479.
[4] H.-Q. Do, J. Daugulis, J. Am. Chem. Soc. 2007, 129, 12404–
12405.
[5] a) A. Klapars, J. C. Antilla, X. Huang, S. L. Buchwald, J. Am.
Chem. Soc. 2001, 123, 7727–7729; b) J. C. Antilla, J. M. Baskin,
T. E. Barder, S. L. Buchwald, J. Org. Chem. 2004, 69, 5578–
5587; c) H. J. Cristau, P. P. Cellier, J. F. Spindler, M. Taillefer,
Eur. J. Org. Chem. 2004, 695–709; d) H. J. Cristau, P. P. Cellier,
J. F. Spindler, M. Taillefer, Chem. Eur. J. 2004, 10, 5607–5622;
e) D. P. Phillips, A. R. Hudson, B. Nguyen, T. L. Lau, M. H.
McNeill, J. E. Dalgard, J.-H. Chen, R. J. Penuliar, T. A. Miller,
L. Zhi, Tetrahedron Lett. 2006, 47, 7137–7138.
[6] X. Guo, H. Rao, H. Fu, Y. Jiang, Y. Zhao, Adv. Synth. Catal.
2006, 348, 2197–2202.
[7] K. W. Anderson, R. E. Tundel, T. Ikawa, R. A. Altman, S. L.
Buchwald, Angew. Chem. Int. Ed. 2006, 45, 6523–6527.
[8] A. Kiyomori, J.-F. Marcoux, S. L. Buchwald, Tetrahedron Lett.
1999, 40, 2657–2660.
[9] R. A. Altman, S. L. Buchwald, Org. Lett. 2006, 8, 2779–2782.
[10] L. Zhu, L. Cheng, Y. Zhang, R. Xie, J. You, J. Org. Chem.
2007, 72, 2737–2743.
1-[5-(2-Ethoxypyridin-3-yl)pyridin-2-yl]-1H-benzimidazole
(24):
Chromatography (eluent EtOAc/dichloromethane, 10:1 v/v) yielded
24 as a white solid in 96% yield, m.p. 106.9–107.7 °C. 1H NMR
(400 MHz, CDCl3): δ = 8.80 (d, J = 2.0 Hz, 1 H), 8.62 (s, 1 H),
8.21 (dd, J = 4.8, 1.6 Hz, 1 H), 8.15 (dd, J = 8.8, 2.8 Hz, 1 H), 8.11
(dd, J = 7.2, 1.2 Hz, 1 H), 7.88 (dd, J = 7.2, 1.6 Hz, 1 H), 7.69 (dd,
J = 7.2, 2.0 Hz, 1 H), 7.63 (d, J = 8.0 Hz, 1 H), 7.42–7.34 (m, 2
H), 7.02 (dd, J = 7.2, 5.2 Hz, 1 H), 4.47 (q, J = 7.2 Hz, 2 H), 1.41
(t, J = 7.2 Hz, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 160.9,
149.7, 149.0, 147.3, 145.1, 141.7, 139.7, 138.6, 132.5, 131.3, 124.6,
123.6, 121.0, 120.3, 117.4, 113.8, 113.0, 62.5, 14.9 ppm. MS (EI)
m/z 316 (M+ 100%). HRMS (ES+) calcd. for C19H16N4O+H: m/z
317.13969; found m/z 317.13975. IR: ν = 3141, 2975, 2901, 1589,
˜
1494, 1457, 1230, 1037, 731 cm–1.
1-[5-(2-Ethoxypyridin-3-yl)pyrimidin-2-yl]-1H-benzimidazole (25).
One-Pot Procedure: 5-Bromo-2-iodopyrimidine (7, 0.570 g,
2.0 mmol) and 1,10-phenanthroline (0.072 g, 0.40 mmol) were
added to a mixture of benzimidazole (1, 0.284 g, 2.4 mmol),
Cs2CO3 (1.304 g, 4.0 mmol) and CuI (0.038 g, 0.20 mmol) in dry
degassed DMF (4 mL). The mixture was stirred and heated under
argon at 80 °C until TLC monitoring showed the reaction was com-
plete (17 h). There was then added, under argon, (2-ethoxypyridin-
3-yl)boronic acid (21, 0.367 g, 2.2 mmol), Pd(PPh3)2Cl2 (0.084 g,
0.12 mmol), 1,4-dioxane (10 mL) and Na2CO3 (1 , 4.4 mL) and
stirring was continued at 80 °C for 17 h. The reaction was cooled
to room temperature, the solvent removed in vacuo and EtOAc
(100 mL) was added to the residue which was washed with brine
(3ϫ50 mL). The organic layer was separated, dried with MgSO4
and concentrated in vacuo. The product was purified by column
chromatography on silica (eluent DCM/EtOAc, 1:1 v/v) to yield 25
as a white solid (0.425 g, 67%) spectroscopically identical to the
[11] H.-C. Ma, X. Z. Jiang, J. Org. Chem. 2007, 72, 8943–8946.
[12] Y.-Z. Huang, J. Gao, H. Ma, H. Miao, J. Xu, Tetrahedron Lett.
2008, 49, 948–951.
[13] J. Lan, L. Chen, X. Yu, J. You, R. Xie, Chem. Commun. 2004,
188–189.
[14] V. Collot, P. R. Bovy, S. Rault, Tetrahedron Lett. 2000, 41,
9053–9057.
Eur. J. Org. Chem. 2008, 2746–2750
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
2749